Recent Advances in Molecular Biomarkers in Multiple Myeloma - Episode 3

Evidence Around Venetoclax for Patients with t(11;14) Translocation in MM

,

Drs Shaji Kumar and Jonathan Kaufman review the BELLINI trial, as well as provide an overview of other investigational studies of venetoclax for the treatment of patients with t(11;14) translocation with relapsed refractory multiple myeloma.